Gevo
GEVO· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -4.3% in FY2025
Paul D. Bloom is the CEO of Gevo and was paid $2.0M in FY2025 (Dec), up 37%.
Pay$100 in the stock at the end of FY20 → $47
Executives6
See all- 1Patrick R. GruberFormer Chief Executive OfficerFY2025
- 2Paul D. BloomChief Executive OfficerFY2025
- 3Christopher M. RyanPresident and Chief Operating OfficerFY2025
- 4Oluwagbemileke (Leke) AgiriChief Financial OfficerFY2025
- 5L. Lynn SmullFormer Chief Financial OfficerFY2025
- 6Andrew L. ShaferChief Customer, Marketing and Brand OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allGevo paid its 6 named executives $10.6M in total in FY2025 (Dec). CEO Paul D. Bloom was paid $2.0M of that.
| Name | |||
|---|---|---|---|
| Patrick R. GruberFormer Chief Executive Officer | Not disclosed | ||
| Paul D. BloomChief Executive Officer | |||
| Christopher M. RyanPresident and Chief Operating Officer | |||
| Oluwagbemileke (Leke) AgiriChief Financial Officer | Not disclosed | Not disclosed | |
| L. Lynn SmullFormer Chief Financial Officer | |||
| Andrew L. ShaferChief Customer, Marketing and Brand Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Gary W. MizeLead independent director · 14 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
- Patrick R. GruberDirector · 18 yr on the boardNot independent—Paid as an executive
- Jaime GuillenDirector · 4 yr on the boardIndependentAudit (Chair)—Paid as an executive
- James J. BarberDirector · 0 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 9, 2026 | FY2025 |
| Annual report | 10-K | Mar 5, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 9, 2025 | FY2024 |
| Annual report | 10-K | Mar 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 9, 2024 | FY2023 |
| Annual report | 10-K | Mar 7, 2024 | FY2023 |